These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27342839)

  • 1. Dose-volume analysis of predictors for chronic gastrointestinal complications in patients with cervical cancer treated with postoperative concurrent chemotherapy and whole-pelvic radiation therapy.
    Isohashi F; Mabuchi S; Akino Y; Yoshioka Y; Seo Y; Suzuki O; Tamari K; Yoshino K; Sawada K; Ueda Y; Kobayashi E; Sumida I; Mizuno H; Okubo H; Kimura T; Ogawa K
    J Radiat Res; 2016 Nov; 57(6):668-676. PubMed ID: 27342839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative concurrent nedaplatin-based chemoradiation therapy for early-stage cervical cancer.
    Isohashi F; Yoshioka Y; Mabuchi S; Konishi K; Koizumi M; Takahashi Y; Ogata T; Maruoka S; Kimura T; Ogawa K
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):728-34. PubMed ID: 22727885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative intensity modulated radiotherapy for early-stage cervical cancer.
    Chen Z; Zhu L; Zhang B; Meng M; Yuan Z; Wang P
    BMC Cancer; 2014 Oct; 14():789. PubMed ID: 25354964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogram parameters.
    Isohashi F; Mabuchi S; Yoshioka Y; Seo Y; Suzuki O; Tamari K; Yamashita M; Unno H; Kinose Y; Kozasa K; Sumida I; Otani Y; Kimura T; Ogawa K
    Radiat Oncol; 2015 Aug; 10():180. PubMed ID: 26300325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer: results from a prospective study.
    Chopra S; Dora T; Chinnachamy AN; Thomas B; Kannan S; Engineer R; Mahantshetty U; Phurailatpam R; Paul SN; Shrivastava SK
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):630-5. PubMed ID: 24521678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of late bowel toxicity using three different methods of contouring in patients undergoing post-operative radiation for cervical cancer.
    Chopra S; Krishnatry R; Dora T; Kannan S; Thomas B; Sonawone S; Engineer R; Paul S; Phurailatpam R; Mahantshetty U; Shrivastava S
    Br J Radiol; 2015; 88(1055):20150054. PubMed ID: 26394195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute gastrointestinal toxicity and bowel bag dose-volume parameters for preoperative radiation therapy for retroperitoneal sarcoma.
    Mak KS; Phillips JG; Barysauskas CM; Lee LK; Mannarino EG; Van Benthuysen L; Raut CP; Mullen JT; Fairweather M; DeLaney TF; Baldini EH
    Pract Radiat Oncol; 2016; 6(5):360-366. PubMed ID: 27009922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.
    Poorvu PD; Sadow CA; Townamchai K; Damato AL; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1262-8. PubMed ID: 23182395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy.
    Mundt AJ; Mell LK; Roeske JC
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1354-60. PubMed ID: 12873680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bag and loop small bowel contouring strategies differentially estimate small bowel dose for post-hysterectomy women receiving pencil beam scanning proton therapy.
    Xu MJ; Kirk M; Zhai H; Lin LL
    Acta Oncol; 2016 Jul; 55(7):900-8. PubMed ID: 26927612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-volume analysis of acute gastrointestinal complications in cervical cancer undergoing definitive concurrent chemoradiation.
    Kumar A; Tudu R; Singh R; Raina P
    J Cancer Res Ther; 2021; 17(1):170-173. PubMed ID: 33723150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Body Mass Index and Weight Change on Late Gastrointestinal Toxicity in Locally Advanced Cervical Cancer Treated With Intensity-modulated Radiotherapy.
    Lee J; Chang CL; Lin JB; Wu MH; Sun FJ; Wu CJ; Tai HC; Hsu SM; Chen YJ
    Int J Gynecol Cancer; 2018 Sep; 28(7):1377-1386. PubMed ID: 29994908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose--volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancer.
    Chen RC; Mamon HJ; Ancukiewicz M; Killoran JH; Crowley EM; Blaszkowsky LS; Wo JY; Ryan DP; Hong TS
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e513-7. PubMed ID: 22436781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
    Serkies K; Jassem J
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the irradiated small bowel volume still a predictor for acute lower gastrointestinal toxicity during preoperative concurrent chemo-radiotherapy for rectal cancer when using intensity-modulated radiation therapy?
    Xu B; Guo Y; Chen Y; Lu H; Tang T; Yue Z; Guan G; Chi P; Lin C
    Radiat Oncol; 2015 Dec; 10():257. PubMed ID: 26684643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin.
    Simpson DR; Song WY; Moiseenko V; Rose BS; Yashar CM; Mundt AJ; Mell LK
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e81-6. PubMed ID: 22516388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy.
    Roeske JC; Bonta D; Mell LK; Lujan AE; Mundt AJ
    Radiother Oncol; 2003 Nov; 69(2):201-7. PubMed ID: 14643959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric planning study for the prevention of anal complications after post-operative whole pelvic radiotherapy in cervical cancer patients with hemorrhoids.
    Baek JG; Kim EC; Kim SK; Jang H
    Br J Radiol; 2015; 88(1056):20150223. PubMed ID: 26395671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric parameters predictive of acute gastrointestinal toxicity in patients with anal carcinoma treated with concurrent chemotherapy and intensity-modulated radiation therapy.
    DeFoe SG; Kabolizadeh P; Heron DE; Beriwal S
    Oncology; 2013; 85(1):1-7. PubMed ID: 23736101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of survival and chronic gastrointestinal toxicities in patients with locally advanced cervical cancer, treated by conventional or intensity-modulated radiation technique].
    Gamelon-Bénichou C; Oldrini S; Charra-Brunaud C; Vogin G; Salleron J; Peiffert D
    Cancer Radiother; 2017 May; 21(3):171-179. PubMed ID: 28457817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.